News NICE close to clearing Cancer Drugs Fund backlog Only five drugs left to assess from old scheme.
News NICE recommends Celgene pancreatic cancer drug Abraxane finally gets NHS funding following price cut.
News Roche's Tecentriq hits trouble with NICE in bladder cancer Cancer Drugs Fund could cover costs in first line use.
News Teva's Cinqaero to challenge Nucala after clearing NICE Discount swings NICE decision, drug will compete with GSK rival
News Disappointment as government delays pharma-friendly policies Proposals fall short of ambitions of Accelerated Access Review.
News Alexion price cut opens up Strensiq to more patients Managed access scheme will control costs to NHS.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
